Detected ·
BioNYRA
——
Gulman Ventures announces investment in BioNYRA via Apollo Health Ventures. BioNYRA is developing a bispecific immunology and inflammation pipeline targeting two inflammatory pathways simultaneously, with clinical milestones expected by late 2026.
- Website
- —
- —
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-15 09:06:09 UTC
- Signal ID
- e5605c1c-886d-4fe0-ad97-b2f425851dc1
As the API returns it
{
"id": "e5605c1c-886d-4fe0-ad97-b2f425851dc1",
"created_at": "2026-04-15T09:06:09.215793Z",
"company_name": "BioNYRA",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Gulman Ventures announces investment in BioNYRA via Apollo Health Ventures. BioNYRA is developing a bispecific immunology and inflammation pipeline targeting two inflammatory pathways simultaneously, with clinical milestones expected by late 2026.*"
}